FIELD: medicine.
SUBSTANCE: invention refers to medicine, more specifically to pharmacology, and concerns the use of N-carbamoyl-methyl-4-phenyl-2-pyrrolidone (fonturacetam) in a model of chronic moderate unpredictable stress.
EFFECT: based on the results of the conducted studies, the use of N-carbamoyl-methyl-4-phenyl-2-pyrrolidone is proposed to increase the level of brain neurotrophic factor (BDNF) in the blood of animals in a model of chronic unpredictable moderate stress.
1 cl, 1 dwg, 10 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PHENOTYPE DETERMINATION OF STRESSED RATS WITH SIMULATED PHOBIC ANXIETY DISORDER | 2024 |
|
RU2830034C1 |
| 9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
| LOW MOLECULAR WEIGHT MIMETIC OF BRAIN NEUROTROPHIC FACTOR WITH ANALGESIC, ANXIOLYTIC AND ANTIADDICTIVE EFFECTS | 2020 |
|
RU2759023C2 |
| NOVEL COMPOSITIONS OF N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE FOR TREATING AND PREVENTING OBESITY | 2019 |
|
RU2732245C1 |
| GALACTOOLIGOSACCHARIDE COMPOSITION FOR USE IN PREVENTING OR TREATING COGNITIVE DYSFUNCTION AND EMOTIONAL DISTURBANCES IN NEUROPSYCHIATRY ILLNESSES OR AGEING | 2014 |
|
RU2663696C2 |
| N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE NEW COMPOSITION | 2017 |
|
RU2696277C2 |
| ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
| AGENT POSSESSING ANXIOLYTHIC ACTION, ON BASIS OF HYDROGENATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND WAY OF ITS APPLICATION | 2007 |
|
RU2338533C1 |
| METHOD FOR SIMULATING CHRONIC EMOTIONAL AND INFORMATION STRESS IN EXPERIMENT | 2018 |
|
RU2697655C1 |
| NOVEL COMPOSITIONS OF N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE | 2018 |
|
RU2699669C1 |
